The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update-Reference-Cited by-同舟云学术

The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update

Published:2020-03 Issue:2S Volume:14 Page:1-91
ISSN:1932-0620
Container-title:Journal of Addiction Medicine
language:en
Short-container-title:

Author:

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference152 articles.

1. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice;Sigmon;Am J Drug Alcohol Abuse,2012

2. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use;Kampman;J Addict Med,2015

3. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved;Degenhardt;Drug Alcohol Depend,2009

4. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: A study of statewide discharge data;Schranz;Ann Intern Med,2018

5. Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol;Compton;Drug Alcohol Depend,2013

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization;Journal of Substance Use and Addiction Treatment;2024-12

2. Self-help groups and opioid use disorder treatment: An investigation using a machine learning-assisted robust causal inference framework;International Journal of Medical Informatics;2024-10

3. Characterization of Oral Ketamine Use: A Retrospective Review;Journal of Pain & Palliative Care Pharmacotherapy;2024-09-12

4. Effect of N-acetylcysteine on craving in substance use disorders (SUD): a meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2024-09-06

5. Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022;Addiction;2024-08-16